Apogee Therapeutics to Participate at the Stifel 2025 Virtual Immunology and Inflammation Forum
Provided By GlobeNewswire
Last update: Sep 3, 2025
SAN FRANCISCO and BOSTON, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc., (Nasdaq: APGE), today announced that members of management will participate in a fireside chat at the Stifel 2025 Virtual Immunology and Inflammation Forum on Tuesday, September 16, 2025, at 11:30 a.m. E.T.
Read more at globenewswire.com
